Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2022-12-23

Coasr evaluation of treatment modalities in cancer patients

Objetivo



Several centers in Eastern Europe collaborate substantially in multicenter phase III clinical trials.
In 1993 Eastern European centers entered 446 patients in EORTC clinical trials.
The vast majority of these patients came from Croatia, The Czech Republic, Slovakia, Hungary, Poland and Slovenia.
The participating Eastern European centers contributed to an important amount to clinical trials regarding treatments for lung cancer, breast cancer, gynaecological cancers, genito-urinary cancer, leukemia and other cancers.

For these common cancers, economic evaluations are currently being carried out or have been planned for the near future with support through the Biomedical and Health Research Program. Key economic data included in the Case Report Forms for a range of ongoing and planned clinical trials (e.g. protocols 55931 in ovarian cancer and 08923 in lung cancer) will be available for most ofthese Eastern European Centers as for Western European centers. Little is known about the relative costs of treating patients with cancer in Eastern European centers neither about differences in treatment patterns and costs between these centers. The same, and even more stringent economic restrictions on the supply of medical services exist in these countries however and the need for sound assessment of costs versus benefits of treatments which are proposed for general adoption after rigorous clinical research, is as urgent as in EC countries.

For Eastern European countries which are in the process of building up modern health care delivery systems, systematic economic evaluations could substitute for blunt cost containment measures and lead to more optimal allocation of health care investments and hence to more health for more patients achieved with the available financial means.

Extrapolation of cost-effectiveness outcomes from a Western context to an Eastern context is not straightforward and no data exist which can indicate how such an extrapolation has to be done. Hence the specific situation in Eastern Europe requires local clinical and economic input when performing economic evaluations. More than for EC countries, investment is needed in collecting basic economic information and gaining know-how concerning costing and financing mechanisms. Central methodological expertise is necessary as well to analyse the results of the local field research and put them into context. At the same time the economic evaluation know-how presently being built up at the EORTC Data Center and in EORTC clinical cooperative groups will be shared with Eastern European centers and there will be spinn offs in both directions regarding mechanisms to ensure efficiency.

Ámbito científico (EuroSciVoc)

CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural. Véas: El vocabulario científico europeo..

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Para utilizar esta función, debe iniciar sesión o registrarse

Programa(s)

Programas de financiación plurianuales que definen las prioridades de la UE en materia de investigación e innovación.

Tema(s)

Las convocatorias de propuestas se dividen en temas. Un tema define una materia o área específica para la que los solicitantes pueden presentar propuestas. La descripción de un tema comprende su alcance específico y la repercusión prevista del proyecto financiado.

Convocatoria de propuestas

Procedimiento para invitar a los solicitantes a presentar propuestas de proyectos con el objetivo de obtener financiación de la UE.

Datos no disponibles

Régimen de financiación

Régimen de financiación (o «Tipo de acción») dentro de un programa con características comunes. Especifica: el alcance de lo que se financia; el porcentaje de reembolso; los criterios específicos de evaluación para optar a la financiación; y el uso de formas simplificadas de costes como los importes a tanto alzado.

CSC - Cost-sharing contracts

Coordinador

EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER
Aportación de la UE
Sin datos
Dirección
83,Avenue Emanuel Mounier 83, bte 11
1200 BRUXELLES
Bélgica

Ver en el mapa

Coste total

Los costes totales en que ha incurrido esta organización para participar en el proyecto, incluidos los costes directos e indirectos. Este importe es un subconjunto del presupuesto total del proyecto.

Sin datos

Participantes (3)